STAT+: Cooling demand for new lab space in Boston could be good news for biotech companies
Amid a bumpy few years for development in Boston, the business of building lab space…
Author: STAT
STAT+: Thrive founders launch new blood testing startup to spot when cancer returns
Among the many anxiety-inducing issues faced by cancer patients is the question of whether the…
Opinion: Unseen mental health experts: people with mental illness
When I was seven years old, I watched as police carted my father out of…
Opinion: Listen: The ‘First Opinion Podcast’ live from Boston: Jay Baruch returns
In a special event as part of STAT’s Open Doors initiative, the “First Opinion Podcast”…
Covid-19 vaccines were a success, but mRNA still has a delivery problem. Two startups have an unorthodox solution
This story has been adapted from the STAT Report “The future of messenger RNA: Covid-19…
Fentanyl isn’t just causing overdoses. It’s making it harder to start addiction treatment
Doctors are reporting a troubling trend when it comes to fentanyl. The powerful drug, they…
After decades of setbacks, scientists make strides toward the holy grail of male birth control
The headlines spelled the end of a short-lived scientific hope: “Male birth control study nixed…
Chelsea Clinton on abortion care and the connection between democracy and women’s health
To pundits, the midterm election was supposed to be a referendum on inflation. They predicted…
.jpg)
STAT+: ‘If this works, it changes everything’: Altos Labs founders lay out plan to reverse disease
BOSTON — The executives behind Altos Labs would really, really like people to stop saying…
STAT+: Hospital systems Sanford, Fairview plan to create $14 billion Midwest powerhouse
Two not-for-profit Midwest hospital systems are seeking to merge, creating what would be a health…
‘I pushed back’: Fauci on how his response to Trump on Covid turned him into ‘public enemy No. 1’
As he faces the possibility of increased scrutiny from what is likely to be a…
STAT+: Walmart agrees to pay $3.1 billion in latest settlement stemming from the opioid crisis
In the latest fallout from the opioid crisis that swept the U.S., Walmart agreed to…
Perfection is too high a bar for CRISPR treatments, says STAT Biomedical Innovation Award winner David Liu
BOSTON — In science journalism, there’s a well-worn technique reporters reach for when they’re interviewing…
White House science adviser Alondra Nelson on the midterms, the cancer moonshot, and a book in the works
Science, according to President Joe Biden’s deputy science adviser Alondra Nelson, is more bipartisan than…
White House’s Jha isn’t predicting a holiday Covid surge this year
Ashish Jha, the White House Covid-19 coordinator, predicted Tuesday that the United States will not…
STAT+: Amazon jumps into direct-to-consumer telehealth, launching a rival to Ro and Hims
True to its e-commerce expertise, Amazon is jumping into the world of direct-to-consumer telehealth. On…
Amazon launches new health venture, Google tests search in health care, & Maven’s $90M round
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: Pharmalittle: Walmart to pay $3.1 billion to settle opioid claims; Indian Covid vaccine underwent troubling approval process
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: Spain’s antitrust regulator fines drugmaker for ‘excessive’ pricing of a rare disease drug
Antitrust regulators in Spain have fined a drugmaker $10.6 million for years of “excessive” price…
STAT+: More drugmakers are expanding access in poorer countries, but progress continues to lag overall
For the first time, many of the world’s largest pharmaceutical companies are taking concrete steps…
Opinion: Replace the failure of Medicare Advantage with ‘Medicare Part F’
Medicare Advantage began life as a brilliant idea: a public-private partnership to keep older people…
The FDA has banned certain vapes and medicines. We still bought these 13 products in its backyard
WHITE OAK, Md. — The Food and Drug Administration, as the name suggests, is supposed…
‘A very worrying scenario’: Internal documents on India Covid-19 vaccine raise troubling questions about approval process
As the Covid-19 pandemic spread across the world two years ago, one of India’s leading…
STAT+: 5 looming questions about the exodus of young life scientists from academia
The unprecedented departure of young life science Ph.D.s and postdocs from academia raises all sorts…
STAT+: Immunogen wins FDA approval for targeted medicine to treat advanced ovarian cancer
The Food and Drug Administration on Monday approved a new treatment for patients with advanced…
University of California academic workers go out on strike to demand higher wages
Any other Monday morning, Josh Mesfin would have been in the lab, performing surgery on…
STAT+: She was a celebrated oncologist. Why did she hide her breast cancer until it was too late?
When Barrett Rollins walked into the bathroom of his Beacon Hill home, he was stunned…
Brains of Black Americans age faster, study finds, with racial stressors a likely factor
The brains of Black adults in the U.S. age more quickly than those of white…
STAT+: Despite higher dose, Stoke Therapeutics drug not active enough against childhood epilepsy
Stoke Therapeutics said Monday that a higher dose of its experimental drug for epilepsy reduced…
STAT+: Pharmalittle: Roche Alzheimer’s drug fails in two studies; Indivior bets on addiction market with deal to buy Opiant
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Maven raises $90 million for women’s and family health amid a funding drought
Women’s and family health tech startup Maven Clinic announced Monday it has raised $90 million…
Moderna data suggests new Covid booster is more effective against Omicron variants
New data indicate Moderna’s Covid bivalent booster may be more effective against currently circulating Omicron…
STAT+: After blazing trails in RNA-targeted drugs, Ionis jumps into gene editing
Ionis Pharmaceuticals, the California company that turned RNA-targeting medicines from an unproven idea into blockbuster…
STAT+: Google travels far from Silicon Valley to test the power of search tools in health care
Mile Bluff Medical Center is a long way from Silicon Valley. The 40-bed hospital is…
Opinion: Better access to amyloid-PET scans won’t reduce racial inequities in Alzheimer’s disease
At first glance, it might appear that better access to so-called amyloid-PET scans could compensate…
.jpg)
Watch: A conversation with the 2022 STAT Wunderkinds
Each year, STAT sets out to celebrate the unheralded heroes of science and medicine, poring…
STAT+: With VillageMD investment, Cigna bets on value-based care for a younger, healthier crowd
These days, if you’re an insurer and you’re not buying into the health care provider…
STAT+: Boom and bust: Whose biotech VC assets have grown and shrunk the most?
Money has gushed into the biotech industry over the last couple of years, as the…
STAT+: Roche’s experimental Alzheimer’s treatment fails to slow cognitive decline across two clinical trials
Roche reported negative results Monday from a pair of clinical trials investigating an antibody treatment…
Meet the 2022 STAT Wunderkinds
Read their stories. Read Original Article: Meet the 2022 STAT Wunderkinds »
A Democratic Senate improves the outlook for Biden health and science priorities, including key nominees
WASHINGTON — The outlook for the White House’s health and science priorities just got a…
STAT+: Head of MassBio trade group is out after serving just over a year
Barely a year after he was named head of the Massachusetts Biotechnology Council, former state…
STAT+: Pharmalittle: Lilly says fake Twitter account offered free insulin; AstraZeneca drops plans for Covid shot in the U.S.
And so, another working week will soon draw to a close. Not a moment too…
Opinion: Violence against health care workers is on the rise. They deserve protection
There is no place for violence in civil society. Yet stabbings, shootings, threats and other…
STAT+: Unexpected troubles hit large medical billing firm R1 RCM, part-owned by Ascension
The stock price of R1 RCM tanked by roughly 50% this week after the large…
STAT+: Unexpected troubles hit large medical billing firm R1 RCM, part-owned by Ascension
The stock price of R1 RCM tanked by roughly 50% this week after the large…
Opinion: Lessons from polio about the need to vaccinate kids against Covid-19
As pediatricians, epidemiologists, and professors of public health — as well as mothers — we…
STAT+: Telehealth companies that prescribed controlled substances during the pandemic brace for business to change
Health tech companies that have taken advantage of the possibility to prescribe controlled substances online…
STAT+: Biogen’s new CEO, clear-eyed about company’s challenges, prepares to take the reins
Christopher Viehbacher, who will start as Biogen’s CEO on Monday, knows that running Biogen may…
STAT+: Viatris executive is charged with insider trading scheme involving a friend and former colleague
A high-ranking Viatris executive was charged with insider trading for tipping a friend and former…